» Articles » PMID: 34911993

Inhibition of Class I HDACs Preserves Hair Follicle Inductivity in Postnatal Dermal Cells

Overview
Journal Sci Rep
Specialty Science
Date 2021 Dec 16
PMID 34911993
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Induction of new hair follicles (HFs) may be an ultimate treatment goal for alopecia; however, functional cells with HF inductivity must be expanded in bulk for clinical use. In vitro culture conditions are completely different from the in vivo microenvironment. Although fetal and postnatal dermal cells (DCs) have the potential to induce HFs, they rapidly lose this HF inductivity during culture, accompanied by a drastic change in gene expression. This suggests that epigenetic regulation may be involved. Of the various histone deacetylases (HDACs), Class I HDACs are noteworthy because they are ubiquitously expressed and have the strongest deacetylase activity. This study revealed that DCs from postnatal mice rapidly lose HF inductivity and that this reduction is accompanied by a significant decrease in histone H3 acetylation. However, MS-275, an inhibitor of class I HDACs, preserves HF inductivity in DCs during culture, increasing alkaline phosphatase activity and upregulating HF inductive genes such as BMP4, HEY1, and WIF1. In addition, the inhibition of class I HDACs activates the Wnt signaling pathway, the most well-described molecular pathway in HF development, via increased histone H3 acetylation within the promoter region of the Wnt transcription factor LEF1. Our results suggest that class I HDACs could be a potential target for the neogenesis of HFs.

Citing Articles

Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia.

Xiao Y, Zhang Y, Deng S, Yang X, Yao X Clin Rev Allergy Immunol. 2025; 68(1):22.

PMID: 40024940 DOI: 10.1007/s12016-025-09034-5.


Irisin promotes hair growth and hair cycle transition by activating the GSK-3β/β-catenin pathway.

Kim Y, Lee J, Jang Y, Park A, Kim S, Kim B Exp Dermatol. 2024; 33(8):e15155.

PMID: 39133009 PMC: 11605494. DOI: 10.1111/exd.15155.


Mechanism and application of feedback loops formed by mechanotransduction and histone modifications.

Sun H, Gao Y, Ma X, Deng Y, Bi L, Li L Genes Dis. 2024; 11(5):101061.

PMID: 39071110 PMC: 11282412. DOI: 10.1016/j.gendis.2023.06.030.


BML-281 promotes neuronal differentiation by modulating Wnt/Ca and Wnt/PCP signaling pathway.

Choi J, Gang S, Ramalingam M, Hwang J, Jeong H, Yoo J Mol Cell Biochem. 2023; 479(9):2391-2403.

PMID: 37768498 DOI: 10.1007/s11010-023-04857-2.


Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases.

Gibson F, Hanly A, Grbic N, Grunberg N, Wu M, Collard M Clin Rev Allergy Immunol. 2022; 63(3):447-471.

PMID: 36346551 DOI: 10.1007/s12016-022-08956-8.


References
1.
Meyer M, Benkusky N, Sen B, Rubin J, Pike J . Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells. J Biol Chem. 2016; 291(34):17829-47. PMC: 5016174. DOI: 10.1074/jbc.M116.736538. View

2.
Sharma S, Bhonde R . Genetic and epigenetic stability of stem cells: Epigenetic modifiers modulate the fate of mesenchymal stem cells. Genomics. 2020; 112(5):3615-3623. DOI: 10.1016/j.ygeno.2020.04.022. View

3.
Lawlor L, Yang X . Harnessing the HDAC-histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering. Int J Oral Sci. 2019; 11(2):20. PMC: 6572769. DOI: 10.1038/s41368-019-0053-2. View

4.
Hess-Stumpp H, Bracker T, Henderson D, Politz O . MS-275, a potent orally available inhibitor of histone deacetylases--the development of an anticancer agent. Int J Biochem Cell Biol. 2007; 39(7-8):1388-405. DOI: 10.1016/j.biocel.2007.02.009. View

5.
Morgan R, Ridsdale J, Payne M, Heesom K, Wilson M, Davidson A . LEF-1 drives aberrant β-catenin nuclear localization in myeloid leukemia cells. Haematologica. 2019; 104(7):1365-1377. PMC: 6601079. DOI: 10.3324/haematol.2018.202846. View